Virtue Capital Management, LLC Dyne Therapeutics, Inc. Transaction History
Virtue Capital Management, LLC
- $562 Million
- Q2 2024
A detailed history of Virtue Capital Management, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Virtue Capital Management, LLC holds 22,227 shares of DYN stock, worth $649,028. This represents 0.14% of its overall portfolio holdings.
Number of Shares
22,227Holding current value
$649,028% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
202Shares Held
105MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$234 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$229 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$216 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$187 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$177 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.51B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...